Author

Pol Claria-Ribas

Queen Mary University of London

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell signaling & trafficking· 1 Research Focus:development & morphogenesis· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Research Focus:metabolism & bioenergetics· 1 Organism:mouse· 1

Frequent Co-Authors

Andreas MargrafiD· 1 shared Ayda Henriques SchneideriD· 1 shared Chiara CecconelloiD· 1 shared Dianne CooperiD· 1 shared Duco Steven KoenisiD· 1 shared Isobel Alice BlackselliD· 1 shared Jesmond DalliiD· 1 shared Jianmin CheniD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPharmacology & Toxicology

Andreas MargrafORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Formyl-peptide receptor type 2 activation mitigates secondary organ damage in inflammatory arthritis

Andreas Margraf, Jianmin Chen, Marilena Christoforou, Pol Claria-Ribas, Ayda Henriques Schneider, Chiara Cecconello, Wei Bu, Paul R. C. Imbert, Thomas D Wright, Stefan Russo, Isobel Alice Blacksell, Duco Steven Koenis, Jesmond Dalli, John A. Lupisella, Nicholas R. Wurtz, , Mauro Perretti

This study shows that activating FPR2 with a small molecule agonist reduces cardiac and lung damage in arthritic mice by decreasing inflammation and fibrosis.

bioRxiv · Feb 3, 2025 · PreprintPharmacology & Toxicology